long-term follow up
Showing 1 - 25 of >10,000
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in
Not yet recruiting
- Knee Osteoarthritis
- (no location specified)
Aug 28, 2023
Long Term Follow up in Pediatric Supracondylar Humeral Fracture
Not yet recruiting
- Supracondylar Humerus Fracture
- Elbow Fracture
- (no location specified)
Mar 20, 2023
Titanium Modular Revision Hip System, With Review of Metal Ion
Not yet recruiting
- Hip Surgery
- x-ray
- (no location specified)
Sep 11, 2023
Cancer Survivor, Prostate Carcinoma Trial in Duarte (Educational Intervention, Laboratory Biomarker Analysis, Long-term
Active, not recruiting
- Cancer Survivor
- Prostate Carcinoma
- Educational Intervention
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 31, 2023
Dietary Intervention to Stop Coronary Atherosclerosis in
Enrolling by invitation
- Coronary Artery Disease
- +2 more
- DISCO Intervention
-
Warszawa, PolandNational Institute of Cardiology
Sep 6, 2023
Long Term Follow-Up for RGX-111
Enrolling by invitation
- Mucopolysaccharidosis I
- No Intervention
-
Orange, California
- +2 more
Oct 25, 2023
Long-term Follow-up of RESTORE Study
Enrolling by invitation
- Cancer
- Long-term follow-up of cerena™
- Long-term follow-up of attune™
-
San Francisco, CaliforniaBlue Note Therapeutics
Dec 9, 2022
A Long-Term Follow-Up Study of Participants Exposed to REACT
Not yet recruiting
- Diabetic Kidney Disease
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jun 15, 2023
Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)
Not yet recruiting
- Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
- 2 year follow-up of neurodevelopment using a parental questionnaire
- (no location specified)
Sep 26, 2023
Patient With Anti-GABAbr Antibodies Associated-encephalitis.
Completed
- Autoimmune Encephalitis
- Long-term outcome
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 14, 2023
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
Study of Participants Previously Enrolled in the STARLIGHT Study
Enrolling by invitation
- Stargardt Disease
- Gene Therapy Product-MCO-010
-
Miami, Florida
- +1 more
Sep 15, 2023
Using Phase-resolved Functional Lung MRI in COVID-19
Recruiting
- Pulmonary Function
- Functional lung MRI
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital
Jul 5, 2023
Long Term Efficacy and Safety Trial (Imlifidase administered in the 20-HMedIdeS-19 (PAES) study, Best available treatment
Not yet recruiting
- Long Term Efficacy and Safety
- Imlifidase administered in the 20-HMedIdeS-19 (PAES) study
- Best available treatment administered in the 20-HMedIdeS-19 (PAES) study
- (no location specified)
Jun 30, 2023
l Gene Editing Therapy for Cardiovascular Disease
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Auckland, New Zealand
- +2 more
Oct 31, 2023
Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)
Not yet recruiting
- Chikungunya Virus Infection
- PXVX0317 vaccine booster
- Placebo booster
- (no location specified)
Aug 18, 2023
Patients With Inflammatory Disorders
Enrolling by invitation
- Inflammation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
T-GENVIH-003 LTFU (Long Term Follow Up) Study
Not yet recruiting
- Hernia
- +3 more
- Integra® Gentrix® Surgical Matrix
-
Fort Myers, FloridaSurgical Healing Arts
Sep 12, 2023
After Adoptive Transfer of Genetically Modified Cell Products
Recruiting
- Relapsed Hematologic Malignancy
- Refractory Hematologic Malignancy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 6, 2023
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Recruiting
- Cushing Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Study of Subjects Who Received ICM-203 or Matching Placebo
Not yet recruiting
- Osteoarthritis, Knee
- ICM-203
- Placebo
-
Adelaide, South Australia, Australia
- +1 more
Feb 21, 2023
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Enrolling by invitation
- Kidney Transplant Rejection
- End Stage Renal Disease
- Urine sample
- +2 more
-
Leuven, Belgium
- +5 more
Aug 3, 2023
Long-term Follow-up Study of COVID-19
Recruiting
- COVID-19
-
Wuhan, Hu Bei Province, China
- +1 more
Aug 8, 2023
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Not yet recruiting
- Non Hodgkin Lymphoma
- Long-term Follow-Up
-
Stanford, California
- +4 more
Oct 30, 2023